1 Min Read
April 13 (Reuters) - MabVax Therapeutics Holdings Inc :
* MABVAX THERAPEUTICS RECEIVES CONTINUED LISTING DEFICIENCY NOTICE FOR NASDAQ’S MINIMUM STOCKHOLDERS’ EQUITY REQUIREMENTS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.